101
|
|
|
EGF like domain multiple 8 |
C6orf8, NG3 |
|
102
|
|
|
EGF like, fibronectin type III and laminin G domains |
AGRINL, AGRNL, PIKA |
|
103
|
|
|
Epidermal growth factor receptor |
ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS, PIG61, mENA |
Alzheimer disease, Cerebral arteriovenous malformations, Experimental arthritis, Polycystic kidney disease, Behcet disease, Bile duct neoplasms, Bipolar disorder, Breast cancer, Breast neoplasms, Carcinoma, Hepatocellular carcinoma, Non-small-cell lung carcinoma, Squamous cell carcinoma, Dilated cardiomyopathy, Central nervous system cancer, Cerebral palsy, Chloracne, Cholangiocarcinoma, Colonic neoplasms, Colorectal neoplasms, Craniofacial abnormalities, Dermatitis, Diabetes mellitus type 2, Endometriosis, Esophageal neoplasms, Esophageal squamous cell carcinoma, Gallbladder neoplasms, Giant cell glioblastoma, Glioblastoma, Glioma, Gliosarcoma, Head and neck neoplasms, Hemorrhoid, Inflammatory bowel disease, Kidney failure, Leiomyoma, Lung cancer, Lung neoplasms, Major depressive disorder, Mesothelioma, Nasopharyngeal neoplasms, Non-small cell lung carcinoma, Ocular sarcoidosis, Osteosarcoma, Ovarian neoplasms, Pancreatic neoplasms, Papilloma, Prostatic neoplasms, Scoliosis, Small cell lung carcinoma, Stomach neoplasms, Depression, Urinary bladder neoplasms, Uterine neoplasmsView all (39 more) |
104
|
|
|
Egl-9 family hypoxia inducible factor 1 |
C1orf12, ECYT3, HALAH, HIF-PH2, HIFPH2, HPH-2, HPH2, PHD2, SM20, ZMYND6 |
|
105
|
|
|
Egl-9 family hypoxia inducible factor 3 |
HIFP4H3, HIFPH3, PHD3 |
|
106
|
|
|
Early growth response 1 |
AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZIF268, ZNF225 |
Amyotrophic lateral sclerosis, Ankylosing spondylitis, Juvenile arthritis, Asthma, Autoimmune disease, Brain ischemia, Hepatocellular carcinoma, Cholangitis, Cholelithiasis, Hydronephrosis, Hypoxia, Intrahepatic cholestasis, Juvenile idiopathic arthritis, Lung neoplasms, Mesothelioma, Oligoarticular juvenile idiopathic arthritis, Prostatic neoplasms, SchizophreniaView all (3 more) |
107
|
|
|
Early growth response 2 |
AT591, CMT1D, CMT4E, KROX20 |
Alzheimer disease, Eczema, Autism, Bipolar disorder, Breast cancer, Hepatocellular carcinoma, Charcot-marie-tooth disease, Dejerine-sottas disease, Dementia, Ewing sarcoma, Hereditary motor and sensory neuropathies, Hereditary sensory and motor neuropathy, Hypertrophic neuropathy, Insomnia, Metabolic syndrome, Myocardial ischemia, Neuropathy, congenital hypomyelinating, Osteoarthritis, Peroneal muscle atrophy, Rett syndrome, Roussy-levy syndrome, Sarcoma, Schizophrenia, Selective iga deficiency disease, Spastic paraplegia, Diabetes mellitus type 2View all (11 more) |
108
|
|
|
Early growth response 3 |
EGR-3, PILOT |
|
109
|
|
|
Early growth response 4 |
AT133, NGFI-C, NGFIC, PAT133 |
|
110
|
|
|
EH domain binding protein 1 |
HPC12, NACSIN |
Androgenetic alopecia, Obstructive pulmonary disease, Colorectal cancer, Coronary artery disease, Essential tremor, Hemorrhoid, Major depressive disorder, Metabolic syndrome, Myocardial infarction, Neurotic disorder, Prostate cancer, Prostatic neoplasms, Schizophrenia, Diabetes mellitus type 2, Vesicoureteral reflux |
